Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Chimeric-anti-interleukin-6 monoclonal antibody

EU orphan designation number: EU/3/03/148
Active ingredient: Chimeric-anti-interleukin-6 monoclonal antibody
Indication: Treatment of renal cell carcinoma
Sponsor: Janssen Biologics B.V.
Einsteinweg 101, NL-2333 CB Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/07/2003 Centralised Orphan - Designation EMEA/OD/002/03 (2003)2217 of 30/06/2003
24/08/2011 Orphan - Change name of sponsor EMEA/OD/002/03
30/09/2011 Centralised Orphan - Removal of orphan designation from Community Register